Package: r-bioc-biocgenerics Severity: serious X-Debbugs-CC: [email protected]
Hello everybody, The next release of Bioconductor is planned for the end of this month. Upstream, Bioconductor packages are regression-tested within their release only. As we can not take cross-release stability on our shoulders, we have for some time made all r-bioc-* packages depend on a virtual package called r-api-bioc-<versionnumber>. For this reason, each Bioconductor release causes a transition in Debian. In addition, this year, we are planning a big change for the R packages maintained by the r-pkg-team: we will align our support to only the architectural features supported upstream, which are 64-bit and little-endian. This will tangle with the Bioconductor transition. To clear the path forward, I am opening this RC bug against r-bioc-biocgenerics, which provides r-api-bioc-3.20 at the moment, so that the whole Bioconductor and its reverse dependencies are removed from Testing. While I have not been able to inspect the reverse dependency network of Bioconductor, I am confident that it is limited to bioinformatics packages only, as Bioconductor itself is specialised in this area. Have a nice day, Charles -- Charles Plessy Nagahama, Yomitan, Okinawa, Japan Debian Med packaging team http://www.debian.org/devel/debian-med Tooting from home https://framapiaf.org/@charles_plessy - You do not have my permission to use this email to train an AI -
